RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Apex Biotechnology Stock

Apex Biotechnology EBIT 2024

Apex Biotechnology EBIT

113.22 M TWD

Ticker

1733.TW

ISIN

TW0001733004

In 2024, Apex Biotechnology's EBIT was 113.22 M TWD, a -20.11% increase from the 141.72 M TWD EBIT recorded in the previous year.

The Apex Biotechnology EBIT history

YEAREBIT (undefined TWD)
2024e113.22
2023141.72
2022176.56
2021204.95
2020103.33
2019203.28
2018227.35
2017161
2016245.89
2015300.8
2014289.49
2013349
2012602.6
2011557.6
2010574
2009449.5
2008356.9
2007449.7
2006319.1
2005135.1
2004147.9

Apex Biotechnology Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Apex Biotechnology, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Apex Biotechnology from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Apex Biotechnology’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Apex Biotechnology. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Apex Biotechnology’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Apex Biotechnology’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Apex Biotechnology’s growth potential.

Apex Biotechnology Revenue, EBIT and net profit per share

DateApex Biotechnology RevenueApex Biotechnology EBITApex Biotechnology Net Income
2024e1.93 B undefined113.22 M undefined107.05 M undefined
20231.68 B undefined141.72 M undefined115.78 M undefined
20222.24 B undefined176.56 M undefined181.79 M undefined
20212.13 B undefined204.95 M undefined202.22 M undefined
20202.01 B undefined103.33 M undefined94.8 M undefined
20192.2 B undefined203.28 M undefined113.86 M undefined
20182.04 B undefined227.35 M undefined95.12 M undefined
20171.8 B undefined161 M undefined85.55 M undefined
20161.76 B undefined245.89 M undefined3.18 M undefined
20151.85 B undefined300.8 M undefined261.85 M undefined
20141.79 B undefined289.49 M undefined273.38 M undefined
20131.83 B undefined349 M undefined371.2 M undefined
20122.03 B undefined602.6 M undefined522.7 M undefined
20111.88 B undefined557.6 M undefined526.6 M undefined
20101.75 B undefined574 M undefined453.9 M undefined
20091.44 B undefined449.5 M undefined326.5 M undefined
20081.19 B undefined356.9 M undefined284.3 M undefined
20071.13 B undefined449.7 M undefined402.5 M undefined
20061.03 B undefined319.1 M undefined304.4 M undefined
2005841.7 M undefined135.1 M undefined172 M undefined
2004620 M undefined147.9 M undefined165.5 M undefined

Apex Biotechnology stock margins

The Apex Biotechnology margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Apex Biotechnology. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Apex Biotechnology.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Apex Biotechnology's sales revenue. A higher gross margin percentage indicates that the Apex Biotechnology retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Apex Biotechnology's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Apex Biotechnology's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Apex Biotechnology's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Apex Biotechnology. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Apex Biotechnology's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Apex Biotechnology Margin History

Apex Biotechnology Gross marginApex Biotechnology Profit marginApex Biotechnology EBIT marginApex Biotechnology Profit margin
2024e31.68 %5.87 %5.55 %
202331.68 %8.45 %6.91 %
202225.7 %7.87 %8.1 %
202126.81 %9.61 %9.49 %
202022.55 %5.15 %4.73 %
201926.86 %9.24 %5.18 %
201827.41 %11.12 %4.65 %
201724.04 %8.97 %4.77 %
201627.04 %13.94 %0.18 %
201529.62 %16.28 %14.17 %
201429.33 %16.18 %15.28 %
201331.07 %19.08 %20.29 %
201239.9 %29.74 %25.8 %
201139.93 %29.72 %28.07 %
201043.09 %32.81 %25.94 %
200942.56 %31.24 %22.69 %
200844.22 %29.93 %23.84 %
200750.71 %39.75 %35.58 %
200644.98 %30.97 %29.54 %
200539.76 %16.05 %20.43 %
200448.95 %23.85 %26.69 %

Apex Biotechnology Aktienanalyse

What does Apex Biotechnology do?

Apex Biotechnology Corp is a Taiwan-based company specializing in the development of innovative biotechnology products. The company was founded in 2002 and offers a wide range of products and services to its customers. Apex Biotechnology Corp began with the production of specialty chemicals and enzymes for research and development purposes. Over the years, the company has expanded its business and focused on the development of diagnostic products, dietary supplements, and pharmaceutical products. The company's business model focuses on the development and marketing of biotechnology products. Apex Biotechnology Corp has established advanced research centers and works closely with research institutions and pharmaceutical companies worldwide to develop innovative solutions. The company operates in various sectors, including diagnostics, dietary supplements, and pharmaceuticals. It offers a diverse range of products, including enzyme immunoassays, lateral flow tests, dietary supplements, and pharmaceuticals. Apex Biotechnology Corp has built strong relationships with research institutions and pharmaceutical companies and has successfully marketed its products internationally. Apex Biotechnology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Apex Biotechnology's EBIT

Apex Biotechnology's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Apex Biotechnology's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Apex Biotechnology's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Apex Biotechnology’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Apex Biotechnology stock

How much did Apex Biotechnology achieve in EBIT for the current year?

In the current year, Apex Biotechnology has achieved an EBIT of 113.22 M TWD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Apex Biotechnology.

How has the EBIT of Apex Biotechnology developed in recent years?

The EBIT of Apex Biotechnology has increased by -20.108% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Apex Biotechnology?

The EBIT of Apex Biotechnology is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Apex Biotechnology pay?

Over the past 12 months, Apex Biotechnology paid a dividend of 1.4 TWD . This corresponds to a dividend yield of about 5.02 %. For the coming 12 months, Apex Biotechnology is expected to pay a dividend of 1.4 TWD.

What is the dividend yield of Apex Biotechnology?

The current dividend yield of Apex Biotechnology is 5.02 %.

When does Apex Biotechnology pay dividends?

Apex Biotechnology pays a quarterly dividend. This is distributed in the months of September, July, July, June.

How secure is the dividend of Apex Biotechnology?

Apex Biotechnology paid dividends every year for the past 21 years.

What is the dividend of Apex Biotechnology?

For the upcoming 12 months, dividends amounting to 1.4 TWD are expected. This corresponds to a dividend yield of 5.02 %.

In which sector is Apex Biotechnology located?

Apex Biotechnology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Apex Biotechnology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Apex Biotechnology from 6/14/2024 amounting to 1.1 TWD, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Apex Biotechnology pay the last dividend?

The last dividend was paid out on 6/14/2024.

What was the dividend of Apex Biotechnology in the year 2023?

In the year 2023, Apex Biotechnology distributed 1.3 TWD as dividends.

In which currency does Apex Biotechnology pay out the dividend?

The dividends of Apex Biotechnology are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Apex Biotechnology

Our stock analysis for Apex Biotechnology Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Apex Biotechnology Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.